Show simple item record

dc.contributor.advisorMalan, Sarel F.
dc.contributor.advisorJoubert, Jacques
dc.contributor.authorSharma, Rajan
dc.date.accessioned2018-08-07T13:50:16Z
dc.date.available2018-08-07T13:50:16Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/11394/6228
dc.descriptionDoctor Pharmaceuticae - Dpharm
dc.description.abstractAmong neurological disorders, many of the most devastating disorders are neurodegenerative. Modern research associates excitotoxicity to a variety of neuropathological conditions, suggesting that the neurodegenerative diseases with distinct etiologies may have excitotoxicity as a common pathway. Excitotoxicity occurs through over-stimulation of receptors for excitatory neurotransmitters like the N-methyl-D-aspartate (NMDA) receptors. Due to the relevance of NMDA receptors and excitotoxic processes, the antagonism or modulation of NMDA receptors is used as a therapeutic tool against neurodegenerative diseases. NMDA receptor activity can be modulated by S-nitrosylation and this modulation of NMDA receptor activity can be utilised in the development of neuroprotective drugs.
dc.language.isoen
dc.publisherUniversity of the Western Cape
dc.subjectNeurodegenerative diseases
dc.subjectExcitotoxicity
dc.subjectApoptosis
dc.subjectPolycyclic cage compounds
dc.subjectDrug design
dc.subjectNeuroprotection
dc.subjectN-methyl-D-aspartate (NMDA) receptors
dc.subjectCalcium influx
dc.subjectNitric oxide
dc.subjectNO-donating
dc.subjectS-nitrosylation
dc.titleSynthesis & biological evaluation of neuroprotective molecules with polycyclic scaffolds
dc.rights.holderUniversity of the Western Cape


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record